• A
  • |
  • A
  • Text size

CPT CodeBridge™

Transforming Molecular Diagnostic Testing and Advancing Personalized Medicine

CPT CodeBridge™, the result of a collaboration between the American Medical Association (AMA) and McKesson, is a new system to map Z-Code™ Identifiers to Current Procedural Terminology (CPT®) codes.

The goal of this initiative is to help bring consistency, transparency and clarity to molecular diagnostic (MDx) testing and provide the information necessary for precise test ordering and more accurate reporting. The first release of CPT CodeBridge will be in March 2014.

Challenges Within MDx
There are many challenges within the field of molecular diagnostics which have significant effects on identification, test ordering and tracking, reporting and financial reimbursement.

Right now, no standardized system exists for uniquely identifying these tests or capturing and analyzing the clinical and financial impact of individual tests. Current methods are inefficient and prevent effective medical coverage policy creation, resulting in hindered clinical and financial decision making.

The goal is to align labs, clinicians and payers more closely in order to improve health outcomes and enable broader adoption of personalized medicine.

Lab Participation is Critical
As a member of the laboratory community, your participation is crucial to the mapping process. By mapping Z-Code Identifiers to CPT codes, this system will help streamline processes associated with MDx tests and can make ordering and reporting more accurate. Simply register for a Z-Code Identifier through the McKesson Diagnostic Exchange (DEX) registry and opt-in to share test information with the AMA. There is no fee associated with participation.

Can a Lab Participate?
In order to have your organization’s test information be considered for the map, you must first register with the McKesson Diagnostics Exchange™ (DEX) and apply for a Z-Code Identifier. During the registration process, you will be asked to opt-in to share test information with the AMA for the mapping process.  There is no fee associated with participation. Participation does not guarantee that your test will be mapped to a CPT code.

Note: The AMA will only be using Z-Code Identifier data it receives from the McKesson Diagnostics Exchange for mapping to CPT codes. The AMA will not be using this data to create CPT Category I or Category III codes. However, given the explosive growth of the MoPath section of CPT Category I, the AMA will continue to support labs and test inventors that wish to apply for a CPT Category I code via the CPT Editorial Panel process.